Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion
- PMID: 38891100
- PMCID: PMC11172099
- DOI: 10.3390/cells13110968
Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion
Abstract
Pulmonary adenocarcinoma (PADC) treatment limited efficacy in preventing tumor progression, often resulting in malignant pleural effusion (MPE). MPE is filled with various mediators, especially interleukin-8 (IL-8). However, the role of IL-8 and its signaling mechanism within the fluid microenvironment (FME) implicated in tumor progression warrants further investigation. Primary cultured cells from samples of patients with MPE from PADC, along with a commonly utilized lung cancer cell line, were employed to examine the role of IL-8 and its receptor, CXCR1, through comparative analysis. Our study primarily assessed migration and invasion capabilities, epithelial-mesenchymal transition (EMT), and cancer stem cell (CSC) properties. Additionally, IL-8 levels in MPE fluid versus serum, along with immunohistochemical expression of IL-8/CXCR1 signaling in tumor tissue and cell blocks were analyzed. IL-8/CXCR1 overexpression enhanced EMT and CSC properties. Furthermore, the immunocytochemical examination of 17 cell blocks from patients with PADC and MPE corroborated the significant correlation between upregulated IL-8 and CXCR1 expression and the co-expression of IL-8 and CXCR1 in MPE with distant metastasis. In summary, the IL-8/ CXCR1 axis in FME is pivotal to tumor promotion via paracrine and autocrine signaling. Our study provides a therapeutic avenue for improving the prognosis of PADC patients with MPE.
Keywords: CXCR1; cancer stem cell; epithelial-mesenchymal transition; fluid microenvironment; interleukin-8; interleukin-8/CXCR1 signaling.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.PLoS One. 2013 May 1;8(5):e54659. doi: 10.1371/journal.pone.0054659. Print 2013. PLoS One. 2013. PMID: 23658677 Free PMC article.
-
Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion.Respir Res. 2025 May 10;26(1):180. doi: 10.1186/s12931-025-03263-0. Respir Res. 2025. PMID: 40349069 Free PMC article.
-
Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.Clin Cancer Res. 2013 Feb 1;19(3):643-56. doi: 10.1158/1078-0432.CCR-12-1063. Epub 2012 Nov 13. Clin Cancer Res. 2013. PMID: 23149820 Free PMC article.
-
An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.Mol Biol Rep. 2021 Sep;48(9):6551-6561. doi: 10.1007/s11033-021-06648-8. Epub 2021 Aug 24. Mol Biol Rep. 2021. PMID: 34426905 Review.
-
The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis.Dis Markers. 2019 Nov 20;2019:8023460. doi: 10.1155/2019/8023460. eCollection 2019. Dis Markers. 2019. Retraction in: Dis Markers. 2023 Jul 12;2023:9869643. doi: 10.1155/2023/9869643. PMID: 31827643 Free PMC article. Retracted. Review.
Cited by
-
High CXCL8 expression predicting poor prognosis in triple-negative breast cancer.Anticancer Drugs. 2025 Mar 1;36(3):246-252. doi: 10.1097/CAD.0000000000001678. Epub 2025 Jan 6. Anticancer Drugs. 2025. PMID: 39761194 Free PMC article.
-
Detection of Cancer Stem Cells from Patient Samples.Cells. 2025 Jan 20;14(2):148. doi: 10.3390/cells14020148. Cells. 2025. PMID: 39851576 Free PMC article. Review.
-
Application of an Integrated Single-Cell and Three-Dimensional Spheroid Culture Platform for Investigating Drug Resistance Heterogeneity and Epithelial-Mesenchymal Transition (EMT) in Lung Cancer Subclones.Int J Mol Sci. 2025 Feb 19;26(4):1766. doi: 10.3390/ijms26041766. Int J Mol Sci. 2025. PMID: 40004228 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases